Get started
Author

Z. Batalov

Observed names: Batalov, Zguro, Zguro Batalov
ORCID: 0000-0003-1233-5775
Observed ORCID: 0000-0003-1233-5775
OpenAlex ID: A5086579683
Op0184 Prevalence of Subclinical Giant Cell Arteritis in Patients With Polymyalgia Rheumatica
2022 · E. de Miguel, P. Macchioni, et al. · Annals of the Rheumatic Diseases · 3
PDF
Janus Kinase Inhibitors and Body Weight: Current Evidence and Potential
2026 · Krasimir Kraev, Yordanka Basheva-Kraeva, et al. · Life · 2
PDF
Synovial Joint Fluid Metabolomic Profiles and Pathways Differentiate Osteoarthritis, Rheumatoid Arthritis, and Psoriatic Arthritis
2026 · Ozan Kaplan, Rositsa Karalilova, et al. · Metabolites · 2
PDF
Longitudinal clinical response to Janus kinase inhibitors in systemic sclerosis: a real-life multicentric study across multiple clinical domains
2026 · Stefano Di Donato, Juan José Alegre-Sancho, et al. · Clinical Rheumatology · 1
PDF
Gene and Protein Profiles of CHI3L1 and CHI3L2 in Patients with Rheumatoid Arthritis
2026 · Maria Kazakova, Valentina Mihaylova, et al. · Pharmaceuticals
PDF
Pos0712 What Is the Outcome of Patients With or Without Subclinical Giant Cell Arteritis in Polymyalgia Rheumatica? Preliminary Data of an Observation Study
2023 · E. De Miguel, R. Karalilova, et al. · Annals of the Rheumatic Diseases
PDF
Blocking of the JAK/STAT pathway as a novel therapeutic opportunity in patients with systemic sclerosis.
2022 · Баталов, Згуро, Batalov, Zguro · Bulgarian Portal for Open Science
Pos0248 Subclinical Giant Cell Arteritis in Patients With Polymyalgia Rheumatica Shows a Different Ultrasonographic Pattern Than Patients With Classical Giant Cell Arteritis
2022 · E. De Miguel, P. Macchioni, et al. · Annals of the Rheumatic Diseases
PDF
Works count: 8
Citation count: 8
H-index: 2
I10-index:
Year
Topic
Type